

Unequalled Target Accuracy
Higher Quality

with More Tissue
Volume and
SUREcore Needle

Single use, disposable 18ga needle (20, 22, 25cm ) for existing reusable biopsy handpieces
SUREcore Prime

Reusable biopsy handpiece OPTIMIZED FOR TARGETED BIOPSY
SUREcore Plus

Single use 18ga (20, 22, 25cm) biopsy instrument
coreCARE

“Touch and Go” tissue transfer, preserving tissue integrity and minimizing artifact
Results from over 2500 biopsy samples to date

SoC

SUREcore & coreCARE
More tissue volume by weight
12-21% more volume in Transrectal (TRUS) and Transperineal (TPBP) diagnostic biopsies, respectively

SoC

SUREcore & coreCARE
Less Tissue Fragmentation
72% of SUREcore/coreCARE samples are intact vs 40% of Standard of Care

SoC

SUREcore & coreCARE
Less Tortuosity
60% of SUREcore/coreCARE samples straight vs 41% of Standard of Care
Bibliography
1.Pritzker, KPH, & Nieminen HJ. Needle Biopsy Adequacy in the Era of Precision Medicine and Value-Based Health Care. Arch Pathol Lab Med. 2019 Nov;143(11):1399-1415. doi: 10.5858/arpa.2018-0463-RA. Epub 2019 May 24.
2.Reis, LO et al., The impact of core biopsy fragmentation in prostate cancer. Int Urol Nephrol. 2010 Dec;42(4): 965-969
3.Satasivam, P et al., Fragmentation of TRUS Biopsy Cores Is Influenced by Method of Specimen Retrieval. Urol. 2014; 83 (3): 622-625.
4.Brown, LC et al., Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study. Health Technol Assess. 2018 Jul;22(39):1-176.
5.Stone, N et al., Deflection Analysis of Different Needle Designs for Prostate Biopsy and Focal Therapy. Technol Cancer Res Treat. 2017 Oct; 16(5): 654-661
6.Proctor, J et al., A Novel Full Core 18 Gauge Prostate Biopsy Needle Collects More Tissue Volume by Weight: Results from Initial Comparative Study. Presented at the Engineering and Urology Society, 2022 Annual Meeting of the American Urology Association.
7.Proctor, J et al., A novel prostate biopsy system provides high quality samples for computational pathology. Presented at the Engineering and Urology Society, 2023 Annual Meeting of the American Urology Association.
8.Stefan, C. et al., Higher Quality, Larger Cores Reduce Diagnostic Ambiguity in Prostate Biopsy. Accepted for presentation US and Canadian Academy of Pathology Boston 2025